The aldo-keto reductases catalyze reduction reactions using various aliphatic and aromatic aldehydes/ketones. Most reductases require NADPH exclusively as their cofactors. However, NADPH is much more expensive and unstable than NADH. In this study, we attempted to change the five amino acid residues that interact with the 2'-phosphate group of the adenosine ribose of NADPH. These residues were selected based on a docking model of the YOL151W reductase and were substituted with other amino acids to develop NADH-utilizing enzymes. Ten mutants were constructed by site-directed mutagenesis and expressed in Escherichia coli. Among them, four mutants showed higher reductase activities than wild-type when using the NADH cofactor. Analysis of the kinetic parameters for the wild type and mutants indicated that the k cat /K m value of the Asn9Glu mutant toward NADH increased 3-fold. A docking model was used to show that the carboxyl group of Glu 9 of the mutant formed an additional hydrogen bond with the 2'-hydroxyl group of adenosine ribose. The Asn9Glu mutant was able to produce (R)-ethyl-4-chloro-3-hydroxyl butanoate rapidly when using the NADH regeneration system.
The asymmetric reduction of ketones to optically pure alcohols is an important bioconversion reaction for the synthesis of chiral building blocks by the fine chemical and pharmaceutical industries. Some microbial reductases are capable of reducing the carbonyl groups of various compounds in a chemo-, regio-, and stereo-selective manner [9, 18] . The asymmetric synthesis of optically active ethyl 4-chloro-3-hydroxybutanoate (ECHB) using microbial reductases has received a great deal of attention in the past because (R)-and (S)-ECHB are useful chiral building blocks for the synthesis of certain pharmaceuticals [17, 22, 23] . In particular, the (R)-enantiomer is a precursor of L-carnitine, which increases serum osteocalcin concentrations and thus maintains bone mass in elderly individuals and postmenopausal women [2, 6] . In addition, L-carnitine can be used along with conventional treatment for angina [8] .
Most reductases require the NAD(P)H cofactor for the reduction of ketone substrates. However, since the cofactor is expensive, a cofactor recycling system is usually added to the reductase bioconversion process [14, 15] . Most reductases, including aldo-keto reductase (AKR) family members, employ NADPH exclusively as their cofactors, rather than NADH [7, 16] . Since the NADPH cofactor is much more expensive and unstable than NADH, several research groups have attempted to alter the cofactor preference by rationally altering the cofactor-binding site [1, 3, 4, 13, 21] .
Katzberg et al. [13] engineered yeast reductase Gre2p via site-directed mutagenesis. A mutant was shown to have an enhanced cofactor preference (NADH/NADPH) of 0.9, whereas the wild type had a preference of 0.007 [13] . Banta et al. [1] reported that three amino acids in the cofactor-binding pocket of Corynebacterium 2,5-diketo-Dgluconic acid reductase were important for determining cofactor preference, and they constructed a mutant enzyme via combinatorial mutagenesis. Jung et al. [11] developed a yeast reductase YDL124W mutant that showed an 82-fold increased k cat /K m value for NADH when compared with wild type.
In a previous study, we reported on a Saccharomyces cerevisiae YOL151W (Gre2p) enzyme that was capable of generating (R)-ECHB [17] . A homology model of YOL151W was constructed on the basis of the X-ray crystal structure of Sporobolomyces salmonicolor carbonyl reductase (PDB ID 1Y1P) [5, 12] . In addition, a docking model with ethyl 4-chloro-3-oxo butanoate (ECOB) substrate and the NADPH cofactor was also constructed, and its possible enantioselective reaction mechanism was elucidated [10] .
In this study, we attempted to determine the amino acid residues that interact with the 2'-phosphate group of the adenosine ribose of NADPH using the previously reported docking structure. Using this docking structure, we developed mutant reductases that were capable of producing (R)-ECHB with the NADH cofactor. Their kinetic parameters were determined and computer modeling was conducted. Furthermore, a mutant was used to generate (R)-ECHB by using NADH and formate dehydrogenase as a cofactor and coupling enzyme, respectively.
MATERIALS AND METHODS

Chemicals
Ethyl-4-chloro-3-oxo butanoate, formate dehydrogenase (FDH, Candida boidinii), NAD(P)H, and NAD(P) + were purchased from Sigma-Aldrich Co. (St. Louis, MO, USA). (R)-and (S)-ethyl-4-chloro-3-hydroxy butanoate were received from Cronbio Com (Korea). All other chemicals were of analytical grade.
Reductase and Formate Dehydrogenase Activity Assays Reductase activity was evaluated at 30 o C by measuring the reduction in absorbance at 340 nm for 5-10 min using a spectrophotometer. The reaction mixture (1 ml) consisted of 1 mM ECOB (100 mM stock in DMSO), 0.2 mM NAD(P)H, 50 mM potassium phosphate (pH 6.5) buffer, and 5-10 µl of cell-free extract or 0.5 µg (for NADPH) or 5 µg (for NADH) of the purified reductase. One unit of reductase was defined as the quantity of enzyme that was required to catalyze the oxidation of 1 µmol NAD(P)H in 1 min at 30 o C. The oxidation reaction mixture (1 ml) of formate dehydrogenase consisted of 10 mM sodium formate, 0.2 mM NAD + , 50 mM potassium phosphate (pH 6.5) buffer, and 10 µl of commercial formate dehydrogenase. The reaction rate was monitored using a spectrophotometer and was calculated based on the increase in absorbance at 340 nm for 5-10 min at 30 o C. One unit of formate dehydrogenase was defined as the quantity required to reduce 1 µmol of NAD + in 1 min at 30
Site-Directed Mutagenesis Gly7, Asn9, Ala31, Arg32, and Lys36 residues were mutated into other selected amino acids using a QuikChange lightning sitedirected mutagenesis kit (Stratagene). The PCR primers employed for the preparation of the mutants are shown in Supplementary Fig. S1 .
For the preparation of mutants, the Saccharomyces cerevisiae YOL151 gene (pETR151) [5] 
Expression and Purification of Mutant Reductases
The recombinant plasmids were transformed into E. coli BL21 (DE3) cells. E. coli cells containing each plasmid were cultured at 20 o C in Luria-Bertani medium (1% tryptone, 0.5% yeast extract, and 0.5% NaCl) containing 100 µg/ml of ampicillin. When the cells reached an optical density (OD 600 ) of 0.5, expression was induced via the addition of 1 mM isopropyl thio-β-D-galactoside (IPTG). Cultivation was continued for an additional 24 h, after which the cells were harvested via 10 min of centrifugation at 10,000 ×g at 4 o C and resuspended in a 1/40 volume of 100 mM Tris-HCl buffer (pH 7.5).
The recombinant E. coli cells were disrupted by sonication and each mutant enzyme in the cell extracts was purified as follows. First, each cell-free extract was loaded onto Ni-NTA agarose columns (QIAGEN GmbH, Hilden, Germany) that had been equilibrated with a 100 mM Tris-HCl buffer (pH 7.5) containing 50 mM imidazole and 300 mM NaCl, and then washed with 50 mM imidazole buffer. The mutant reductases were then eluted from the column using 250 mM imidazole buffer. The active fractions were then collected and desalted using PD G10 desalting columns (GE Healthcare Bio-Sciences AB, UK). The purified enzymes were analyzed by SDS-PAGE ( Supplementary Fig. S2 ) and protein concentrations were measured by the Bradford method.
Kinetic Studies of the Mutant Enzymes
Kinetic studies were conducted on the purified wild type and four mutants (Asn9Asp, Asn9Glu, Lys36Arg, and Lys36Tyr). In order to elucidate the K m and k cat values of the wild type and mutants toward ECOB, enzyme assays were conducted in reaction mixtures containing 0.1-50 mM ECOB, 0.5 mM NAD(P)H, and 1.19-11.92 µg/ml purified enzyme. The K m and k cat values of each enzyme toward ECOB were calculated from the Lineweaver-Burk plots. The K m values of the wild type and mutants toward NAD(P)H cofactor were then measured using enzyme assays in reaction mixtures containing excess ECOB (10-fold concentration of K m,ECOB ), 0.01-0.5 mM NAD(P)H cofactor, and 0.189-3.662 µg/ml purified enzyme. The K m value of each enzyme was calculated from the LineweaverBurk plots.
Molecular Modeling
Molecular modeling of docking structures of the wild-type and Asn9Glu mutant enzymes containing ECOB and NADH or NADPH was carried out with the SYBYL 8.1. The atom types of the enzymes were determined based on the AMBER99 force field [19] . The atom types and parameters undefined by the AMBER99 force field for the substrate and cofactors were assigned using the general AMBER force field (GAFF) [20] . Atomic partial charges for the enzymes and the substrate or cofactors were calculated using the AMBER method and the Gasteiger-Huckel method, respectively. A nonbonded cut-off distance of 8Å and a distance-dependent dielectric function were employed in all calculations. The total energies of the docking models were minimized using the Powell minimizer until the rms derivatives were less than 0.005 kcal mol
. The models were visualized using PYMOL (http://www.pymol.org).
Enzymatic Coupling Reaction and Reaction Mixture Analysis
The enantioselectivity of the enzymatic reduction of ECOB was evaluated. The general procedure used for this analysis was as follows: 10 mM ECOB, 1 mM NADH, 0.4 mg of purified reductase, 1 M sodium formate, and 5 units of commercial formate dehydrogenase (toward NAD + ) were mixed in a total volume of 10 ml of potassium phosphate buffer (50 mM, pH 6.5), and the mixture was incubated at 30 o C. The ECHB product was extracted using ethyl acetate and dried via evaporation. After the acetylation step and washing steps, the organic phase was subsequently analyzed using a GC system equipped with a Chirasil-dex column (Varian, Ltd) [10, 11] 
RESULTS AND DISCUSSION
Construction of mutant reductases based on rational design yeast YOL151W reductase was reported to convert the ECOB substrate exclusively into the (R)-ECHB product [17] . In addition, this enzyme was reported to utilize NADPH efficiently as a cofactor (Scheme 1) and NADH inefficiently. NADPH is, however, far more expensive and unstable than NADH. Therefore, development of a YOL151W mutant enzyme that is able to use NADH would make the production of (R)-ECHB more economical.
The homology model of YOL151W and its docking model with ECOB and NADPH were constructed (Fig. 1A) . Structural analysis of the NADPH-binding site using the docking model suggested that the 2'-phosphate group of the adenosine ribose of NADPH was surrounded by five amino acid residues including Gly7, Asn9, Ala31, Arg32, and Lys36. Among these residues, the guanidino nitrogen atom of Arg32 and the ε-amino group of Lys36 were found to be located at a distance of 2.9-3.0 Å from the phosphate oxygen atoms, and seemed to form salt bridges (Fig. 1B) . The amide nitrogen atom of Asn9 was located at a distance of 3.0 Å and formed hydrogen bonds with the phosphate oxygen atoms; thus, they made a hydrophilic pocket for the binding of the phosphate group of the adenosine ribose of NADPH.
In this study, several YOL151W mutants were constructed with the goal of making an "NADH-utilizing reductase." A total of 10 different mutant enzymes were constructed; Gly7 and Ala31 were mutated into Asn or Gln; Asn9 into Asp or Glu; Arg32 into His or Tyr; and Lys36 into Arg or Scheme 1. Schematic presentation of the reduction reactions.
YOL151W wild type reduced ECOB when the NADPH cofactor was used. YOL151W mutant reduced ECOB when the NADH cofactor was used. (A) The three-dimensional homology model was redrawn on the basis of the previously reported structure [10] . (B) Line diagrams of the docking structure of YOL151W with NADPH. The phosphate group at the 2'-oxygen of the adenosine group was surrounded by Asn9, Arg32, and Lys36.
Tyr. After the expression and purification steps, the purity of the mutant reductases was ascertained via SDS-PAGE ( Supplementary Fig. S2 ). Most mutants were successfully expressed and purified except for two mutants (Ala31Asn and Ala31Gln). When the reductase activities of the purified mutant enzymes were tested using ECOB and NADPH as the substrate and cofactor, respectively, three mutants (Asn9Asp, Lys36Arg, and Lys36Tyr) showed very similar activities and the other five mutants showed significantly decreased activities ( Fig. 2A) . When they were subsequently tested using ECOB and NADH, four mutants (Asn9Asp, Asn9Glu, Lys36Arg, and Lys36Tyr) displayed profoundly higher reductase activities (Fig. 2B) . Among the mutants, the purified Asn9Glu exhibited a specific activity of 11.72 U/mg, whereas the purified wild-type reductase exhibited a specific activity of 3.91 U/mg.
Kinetic Parameters of Mutant Reductases
In order to elucidate the enzyme activities in the presence of NADPH or NADH cofactor, kinetic studies were performed using the four mutants, as well as wild-type reductase ( Table 1 ). The mutants tested included Asn9Asp, Asn9Glu, Lys36Arg, and Lys36Tyr. As anticipated, the wild-type enzyme had a very low K m value (0.009 mM) for NADPH but a high K m value (> 0.5 mM) for NADH. Moreover, the k cat /K m ECOB (6,970 min
) in the presence of the NADPH cofactor was significantly higher than that (493 min
) observed in the presence of the NADH cofactor.
Most mutants displayed elevated K m values (0.02-0.27 mM) toward NADPH when compared with the wildtype. Conversely, the four mutants had slightly reduced K m values toward NADH relative to the wild-type. In the case of Asn9Glu, the K m value for NADH was 0.3 mM, which suggested that the NADH cofactor bound tightly within the active pocket of the mutant enzyme. This mutant exhibited a substantially elevated k cat /K m ECOB value with the NADH cofactor (1,440 min
) when compared with that of the wild type (493 min -1 mM -1 ) ( Table 1) . Katzberg et al. [13] developed several Gre2p mutants for the reduction of 2,5-hexanedione, yielding (5S)-hydroxy-2-hexanone and (2S,5S)-hexanediol. The Asn9Glu mutant was found to show high reduction activity toward the diketone substrate in the presence of the NADH cofactor. These previous findings correlated well with our present kinetic results using ECOB and NADH, despite the difference in substrate. To better understand these findings, the detailed molecular basis of the enhancement of NADH binding was determined using homology modeling and docking modeling. Furthermore, coupling reactions between the mutant reductase and formate dehydrogenase for the production of (R)-ECHB with NADH were examined. (A) Reductase activities were measured using the NADPH cofactor. (B) Reductase activities were measured using the NADH cofactor. Table 1 . Kinetic parameters of wild type and mutant enzymes. 
Molecular Basis of Utilizing NADH as a Cofactor by the Mutants
We analyzed binding of the cofactor using minimized docking models. We analyzed the binding region of the terminal phosphate group of NADPH because the presence of the phosphate group is the primary difference between NADPH and NADH. The ECOB and NADPH docked model of the wild-type enzyme indicated that the carbonyl group of ECOB was parallel with the nicotinamide group, and the three residues (Asn9, Arg32, and Lys36) were located near the terminal phosphate group (Fig. 3A) and hydrogen bonded to the three oxygen atoms of the terminal phosphate group of NADPH (2.8-3.0Å, Table 2 ). The Arg32 residue formed an additional hydrogen bond with the 2'-oxygen atom of the ribose group. In contrast, the hydrogen bond between the Arg32 residue and the 2'-oxygen atom of the ribose group was observed in the NADH docking model of the wild-type enzymes, and no hydrogen bonds were observed between the Asn9 and Lys36 residues and NADH (Fig. 3B) . When the Asn9 residue was replaced with Glu, the side chain of the Glu residue moved away from the terminal phosphate group owing to repulsive interactions between the negative-charged atoms, whereas the Arg32 and Lys36 residues formed hydrogen bonds with the phosphate group (Fig. 3C) . The distance between the oxygen atom of the phosphate group and the oxygen atom of the side chain of Glu was 5.5Å. This indicates that the binding affinity of the Asn9Glu mutant enzyme toward NADPH decreases. On the other hand, according to the docking model, the Asn9Glu mutant enzyme with NADH formed a hydrogen bond between the 2'-oxygen atom of the ribose group and the side chain of the Glu9 residue (Fig. 3D ). In comparison with the NADH docking model of the wild-type enzyme, the newly introduced glutamate formed an extra hydrogen bond with NADH and likely stabilized NADH binding. This improved stabilization may increase the efficiency of utilizing NADH as a cofactor by the Asp9Glu mutant enzyme (Table 2) .
Mutant Reductase and FDH Coupling Reaction
Bioconversions by the wild type and Asn9Glu mutant were examined using NADH and commercial FDH as a cofactor and coupling enzyme, respectively. In the case of the wild type (Fig. 4) , the bioconversion yield and the initial rate were 29.3% and 115.3 µmol h -1 mg
, respectively. This low yield and slow initial conversion rate were ) with the NADH cofactor (Table 1) . However, in the case of Asn9Glu, the conversion yield was 66.21% within 120 min of the reaction (Fig. 4) . The initial conversion rate was 347.5 µmol h -1 mg -1
, which was approximately 3-fold higher than that of the wild type. These results clearly demonstrate that the mutant could utilize NADH as a cofactor, which was continuously recycled by FDH.
In this study, we successfully developed several YOL151W mutants that were capable of utilizing NADH as a cofactor, using a rational design approach. Among them, the Asn9Glu mutant displayed a decreased K m value toward NADH and an increased k cat /K m value toward ECOB. Although the k cat /K m values were still lower than that of the wild type toward NADPH, bioconversion in the presence of NADH and FDH as the cofactor and coupling enzyme, respectively, was efficient when the mutant was used. These results suggest that this mutant might be employed for the production of (R)-ECHB. Wild-type and Asn9Glu enzymes were used for the bioconversion of ECOB into (R)-ECHB together with FDH and NADH. Open circles mean the conversion yields of Asn9Glu mutant, and closed ones mean those of the wild type.
